Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 22.85
0.00 (0.00%)
Jun 30, 2025, 11:54 AM CST
Bioray Biotech Revenue
In the year 2024, Bioray Biotech had annual revenue of 201.71M TWD with 5.15% growth. Bioray Biotech had revenue of 115.92M in the half year ending December 31, 2024, with 13.94% growth.
Revenue
201.71M
Revenue Growth
+5.15%
P/S Ratio
3.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
676.02M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |